Researchers Patent Drug Treatment to Boost Protein Production in the Brain
November 30, 2016
As reported in Twin Cities Business on November 23rd, a team of researchers has patented a drug treatment that stimulates the production of progranulin (PGRN), a protein necessary in maintaining the health of the brain’s frontal and temporal lobes. Deficiencies of PGRN have been linked to both FTD and ALS. The researchers — led by the Mayo Clinic’s Rosa Rademakers, who received the Potamkin Prize earlier this year — also patented a benign virus designed to deliver the drug to the brain.
By Category
Our Newsletters
Stay Informed
Sign up now and stay on top of the latest with our newsletter, event alerts, and more…